NovaBay Pharmaceuticals, Inc.

NYSEAM:NBY Voorraadrapport

Marktkapitalisatie: US$3.7m

NovaBay Pharmaceuticals Beheer

Beheer criteriumcontroles 3/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Justin Hall

Algemeen directeur

US$364.1k

Totale compensatie

Percentage CEO-salaris96.1%
Dienstverband CEO8.9yrs
Eigendom CEO0.001%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur4.1yrs

Recente managementupdates

Recent updates

We Think NovaBay Pharmaceuticals (NYSEMKT:NBY) Can Afford To Drive Business Growth

Mar 29
We Think NovaBay Pharmaceuticals (NYSEMKT:NBY) Can Afford To Drive Business Growth

Analyse CEO-vergoeding

Hoe is Justin Hall's beloning veranderd ten opzichte van NovaBay Pharmaceuticals's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$17m

Mar 31 2024n/an/a

-US$19m

Dec 31 2023US$364kUS$350k

-US$17m

Sep 30 2023n/an/a

-US$15m

Jun 30 2023n/an/a

-US$19m

Mar 31 2023n/an/a

-US$17m

Dec 31 2022US$365kUS$350k

-US$16m

Sep 30 2022n/an/a

-US$9m

Jun 30 2022n/an/a

-US$5m

Mar 31 2022n/an/a

-US$5m

Dec 31 2021US$796kUS$329k

-US$7m

Sep 30 2021n/an/a

-US$7m

Jun 30 2021n/an/a

-US$8m

Mar 31 2021n/an/a

-US$11m

Dec 31 2020US$747kUS$286k

-US$11m

Sep 30 2020n/an/a

-US$13m

Jun 30 2020n/an/a

-US$10m

Mar 31 2020n/an/a

-US$8m

Dec 31 2019US$326kUS$260k

-US$10m

Sep 30 2019n/an/a

-US$8m

Jun 30 2019n/an/a

-US$10m

Mar 31 2019n/an/a

-US$9m

Dec 31 2018US$572kUS$260k

-US$7m

Sep 30 2018n/an/a

-US$4m

Jun 30 2018n/an/a

-US$5m

Mar 31 2018n/an/a

-US$6m

Dec 31 2017US$665kUS$228k

-US$7m

Compensatie versus markt: Justin's total compensation ($USD364.15K) is below average for companies of similar size in the US market ($USD655.65K).

Compensatie versus inkomsten: Justin's compensation has been consistent with company performance over the past year.

CEO

Justin Hall (46 yo)

8.9yrs

Tenure

US$364,146

Compensatie

Mr. Justin M. Hall, Esq. has been General Counsel at NovaBay Pharmaceuticals, Inc. since December 2015, Corporate Secretary since July 16, 2017 and President and Chief Executive Officer since June 17, 2019...

Bestuursleden

NaamPositieTenureCompensatieEigendom
Justin Hall
President4.3yrsUS$364.15k0.0014%
$ 50.9
Paul Freiman
Independent Chairman22.5yrsUS$78.08k0.0016%
$ 57.9
Yenyou Zheng
Independent Director5.2yrsUS$74.08k0.0015%
$ 56.4
Mijia Wu
Director8.8yrsUS$40.58k0.0015%
$ 56.4
Pedram Hamrah
Member of Ophthalmic Advisory Board9.1yrsgeen gegevensgeen gegevens
Swan Sit
Independent Director4.9yrsUS$59.08k0.0015%
$ 56.4
Komal Thakore
Member of the Optometry Advisory Board4yrsgeen gegevensgeen gegevens
Amr Kouchouk
Member of the Ophthalmic Advisory Board4yrsgeen gegevensgeen gegevens
John Aljian
Member of the Ophthalmic Advisory Board4yrsgeen gegevensgeen gegevens
Laura Periman
Member of the Ophthalmic Advisory Board4yrsgeen gegevensgeen gegevens
Milap Mehta
Member of the Ophthalmic Advisory Board4yrsgeen gegevensgeen gegevens
Melanie Bennett-Sims
Member of the Ophthalmic Advisory Board4yrsgeen gegevensgeen gegevens

4.1yrs

Gemiddelde duur

50yo

Gemiddelde leeftijd

Ervaren bestuur: NBY's board of directors are considered experienced (4.1 years average tenure).